Slingshot Insights | Cepheid Overview

CEPHEID Overview

Upcoming Projects (CEPHEID)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (CEPHEID)

A Third Opinion: Discussing the current diagnostic landscape for Hepatitis C and the approval of Cepheid's Xpert HCV molecular test.
Tickers: CEPHEID, DHR
Executed On: Feb 07, 2025 at 04:00 PM EST
A Second Opinion: Discussing the current diagnostic landscape for Hepatitis C and the approval of Cepheid's Xpert HCV molecular test.
Tickers: CEPHEID, DHR
Executed On: Jan 31, 2025 at 03:00 PM EST
Discussing the current diagnostic landscape for Hepatitis C and the approval of Cepheid's Xpert HCV molecular test.
Tickers: CEPHEID, DHR
Executed On: Jan 16, 2025 at 12:30 PM EST
A Third Look: Discussing the potential of Cepheid's Xpert Xpress MVP (Assay), a multiplex vaginal panel which enables results within 60 minutes from a single specimen for Bacterial Vaginosis, Vulvovaginal Candidiasis, and Trichomoniasis
Ticker: CEPHEID
Executed On: Feb 02, 2024 at 12:00 PM EST
A Second Look: Discussing the potential of Cepheid's Xpert Xpress MVP (Assay), a multiplex vaginal panel which enables results within 60 minutes from a single specimen for Bacterial Vaginosis, Vulvovaginal Candidiasis, and Trichomoniasis
Ticker: CEPHEID
Executed On: Jan 31, 2024 at 09:00 AM EST
Discussing the potential of Cepheid's Xpert Xpress MVP (Assay), a multiplex vaginal panel which enables results within 60 minutes from a single specimen for Bacterial Vaginosis, Vulvovaginal Candidiasis, and Trichomoniasis
Ticker: CEPHEID
Executed On: Jan 24, 2024 at 03:00 PM EST

Upcoming & Overdue Catalysts (CEPHEID)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (CEPHEID)

Don’t see a strategic initiative related to the company you care about? Create your own!